|

IP-001 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • M.R. Meijerink1

Indications

  • Liver Disease1
  • Liver Metastases1
  • Liver Metastasis Colon Cancer1
  • Liver Cancer1
  • Colorectal Cancer1

Other1 trial

Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.